Drug profile · INN
hydrocortisone acetate
CORTIC-DS 1%
hydrocortisone acetate (CORTIC-DS 1%) is a glucocorticoid receptor agonist. Associated with Lacuna Pharma Pty Ltd. Route of administration: ophthalmic, otic. Current US regulatory status: approved.
Drug details — hydrocortisone acetate
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC, OTIC
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
hydrocortisone acetate (CORTIC-DS 1%) is a glucocorticoid receptor agonist. Associated with Lacuna Pharma Pty Ltd. Route of administration: ophthalmic, otic. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is hydrocortisone acetate?
hydrocortisone acetate (CORTIC-DS 1%) is a glucocorticoid receptor agonist. Associated with Lacuna Pharma Pty Ltd. Route of administration: ophthalmic, otic. Current US regulatory status: approved.
What is the brand name for hydrocortisone acetate?
CORTIC-DS 1% is a marketed brand name for hydrocortisone acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of hydrocortisone acetate?
hydrocortisone acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.